2020
DOI: 10.1101/2020.03.28.012518
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Unraveling the functional role of DNA methylation using targeted DNA demethylation by steric blockage of DNA methyltransferase with CRISPR/dCas9

Abstract: Although associations between DNA methylation and gene expression were established four decades ago, the causal role of DNA methylation in gene expression remains unresolved. Different strategies to address this question were developed; however, all are confounded and fail to disentangle cause and effect. We developed here a highly effective new method using only deltaCas9(dCas9):gRNA site-specific targeting to physically block DNA methylation at specific targets in the absence of a confounding flexibly-tether… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 107 publications
0
2
0
Order By: Relevance
“…In addition, evolving gene editing approaches, including the use of nucleases such as TALENs (transcription activator-like effector nucleases), zinc-finger nucleases, and CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats-CRISPRassociated 9) to instigate a sequence-specific change in the DNA [132][133][134], encouraged the development of gene expression regulation, epigenetic modification, functional gene screening, gene diagnosis, and therapeutic drug discovery [135][136][137][138][139][140]. For example, dCas9 can be fused with DNMTs or TETs to regulate DNA methylation, thereby regulating specific gene expression [141][142][143]. Similarly, dCas9 can be fused with HDACs or HATs to regulate chromatin structure, thereby regulating gene expression [144][145][146].…”
Section: Perspectives For Treatment and Prevention Of Neonatal Chronic Lung Diseasementioning
confidence: 99%
“…In addition, evolving gene editing approaches, including the use of nucleases such as TALENs (transcription activator-like effector nucleases), zinc-finger nucleases, and CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats-CRISPRassociated 9) to instigate a sequence-specific change in the DNA [132][133][134], encouraged the development of gene expression regulation, epigenetic modification, functional gene screening, gene diagnosis, and therapeutic drug discovery [135][136][137][138][139][140]. For example, dCas9 can be fused with DNMTs or TETs to regulate DNA methylation, thereby regulating specific gene expression [141][142][143]. Similarly, dCas9 can be fused with HDACs or HATs to regulate chromatin structure, thereby regulating gene expression [144][145][146].…”
Section: Perspectives For Treatment and Prevention Of Neonatal Chronic Lung Diseasementioning
confidence: 99%
“…Congruently, we found that H3K4me1/2 deficient cells displayed increased mCpG levels within PGCLC enhancers. Therefore, although the importance of mCpG for enhancer activity and gene expression are not fully established [78][79][80] , it is tempting to speculate that the lack of DNA methylation in flies render them less sensitive to H3K4me1/2 loss. Nevertheless, Trr catalytic mutant fly embryos displayed aberrant phenotypes under stress conditions, suggesting that H3K4me1/2 might help to fine-tune enhancer activity under suboptimal conditions.…”
Section: Discussionmentioning
confidence: 99%